Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pearsall

Showing results (341-350 of 386) with videos related to

Pageof 39
Sort By:
Biorxiv : the Preprint Server for Biology|November 19, 2025
ACE-031, a Soluble Activin Type IIB Receptor, Increases Muscle Mass and Strength in the Common Marmoset (Callithrix jacchus)Samuel M Cadena, Sasha Bogdanovich, Tejvir S Khurana, et al.
The American Journal of Pathology|April 23, 2016
Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline MyopathyJennifer Tinklenberg, Hui Meng, Lin Yang, et al.
Bone|January 19, 2010
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeysSutada Lotinun, R Scott Pearsall, Monique V Davies, et al.
Molecular Cancer Therapeutics|February 4, 2010
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growthDianne Mitchell, Eileen G Pobre, Aaron W Mulivor, et al.
Jac-Antimicrobial Resistance|January 19, 2026
A full educational resource review of grey literature resources for vancomycin dosing tutorialsEmma S Kuska, Jen Mlyniec, Kathleen L Wantuch, et al.
Canadian Journal of Pain = Revue Canadienne De La Douleur|May 14, 2021
Consensus Statement for the Prescription of Pain Medication at Discharge after Elective Adult SurgeryHance A Clarke, Varuna Manoo, Emily A Pearsall, et al.
Aging Cell|May 22, 2019
Late-life time-restricted feeding and exercise differentially alter healthspan in obesityMarissa J Schafer, Daniel L Mazula, Ashley K Brown, et al.
International Journal of Methods in Psychiatric Research|August 10, 2019
Indicators of mental disorders in UK Biobank-A comparison of approachesKatrina A S Davis, Breda Cullen, Mark Adams, et al.
Cancer Research|June 17, 2015
Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast CancerSara I Cunha, Matteo Bocci, John Lövrot, et al.
Oncotarget|June 2, 2016
Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinomaXiaoen Wang, Nicolas Solban, Prateek Khanna, et al.
Pageof 39

Showing results (341-350 of 386) with videos related to

Sort By:
Pageof 39
Biorxiv : the Preprint Server for Biology|November 19, 2025
ACE-031, a Soluble Activin Type IIB Receptor, Increases Muscle Mass and Strength in the Common Marmoset (Callithrix jacchus)Samuel M Cadena, Sasha Bogdanovich, Tejvir S Khurana, et al.
The American Journal of Pathology|April 23, 2016
Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline MyopathyJennifer Tinklenberg, Hui Meng, Lin Yang, et al.
Bone|January 19, 2010
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeysSutada Lotinun, R Scott Pearsall, Monique V Davies, et al.
Molecular Cancer Therapeutics|February 4, 2010
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growthDianne Mitchell, Eileen G Pobre, Aaron W Mulivor, et al.
Jac-Antimicrobial Resistance|January 19, 2026
A full educational resource review of grey literature resources for vancomycin dosing tutorialsEmma S Kuska, Jen Mlyniec, Kathleen L Wantuch, et al.
Canadian Journal of Pain = Revue Canadienne De La Douleur|May 14, 2021
Consensus Statement for the Prescription of Pain Medication at Discharge after Elective Adult SurgeryHance A Clarke, Varuna Manoo, Emily A Pearsall, et al.
Aging Cell|May 22, 2019
Late-life time-restricted feeding and exercise differentially alter healthspan in obesityMarissa J Schafer, Daniel L Mazula, Ashley K Brown, et al.
International Journal of Methods in Psychiatric Research|August 10, 2019
Indicators of mental disorders in UK Biobank-A comparison of approachesKatrina A S Davis, Breda Cullen, Mark Adams, et al.
Cancer Research|June 17, 2015
Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast CancerSara I Cunha, Matteo Bocci, John Lövrot, et al.
Oncotarget|June 2, 2016
Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinomaXiaoen Wang, Nicolas Solban, Prateek Khanna, et al.
Pageof 39